Epigenetic reprogramming as a key contributor to melanocyte malignant transformation

Epigenetics

Volumn 6, Issue 4, 2011, Pages 450-464

  Molognoni, Fernanda ^a   Cruz, Adriana T ^a   Meliso, Fabiana M ^a   Morais, Alice S ^a   Souza, Camila F ^a   Xander, Patrícia ^a   Bischof, Jared M ^b   Costa, Fabrício F ^b   Soares, Marcelo B ^b   Liang, Gangning ^c   Jones, Peter A ^c   Jasiulionis, Miriam G ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Anchorage blockade; Epigenetic reprogramming; Malignant melanoma; Pluripotency; Sustained stress

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; HISTONE; MELAN A; MICRORNA; TRICHOSTATIN A;

ARTICLE; CARCINOGENESIS; CELL ANCHORAGE; DNA METHYLATION; ENVIRONMENTAL STRESS; EPIGENETICS; GENE EXPRESSION; HISTONE MODIFICATION; IN VIVO STUDY; MALIGNANT TRANSFORMATION; MELANOCYTE; MELANOMA CELL; MUTATION; NUCLEAR REPROGRAMMING; PHENOTYPE; TUMOR GROWTH; ANIMAL; CELL LINE; CELL TRANSFORMATION; CHEMICALLY INDUCED DISORDER; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; METABOLISM; MOUSE; PHYSIOLOGY;

ANIMALS; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONES; MELANOCYTES; MICE;

EID: 79954477288     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.6.4.14917     Document Type: Article

References (59)

1. Egger G, Liang G, Aparicio A, Jones PA. Epigenetics in human disease and prospects for epigenetic therapy. Nature 2004; 429:457-63.
2. Ehrlich M. DNA hypomethylation, cancer, the immunodeficiency, centromeric region instability, facial anomalies syndrome and chromosomal rearrangements. J Nutr 2002; 132:2424-9.
3. Narayan A, Ji W, Zhang XY, Marrogi A, Graff JR, Baylin SB, et al. Hypomethylation of pericentromeric DNA in breast adenocarcinomas. Int J Cancer 1998; 77:833-8.
4. Gaudet F, Hodgson JG, Eden A, Jackson-Grusby L, Dausman J, Gray JW, et al. Induction of tumors in mice by genomic hypomethylation. Science 2003; 300:489-92.
5. Wu J, Issa JP, Herman J, Bassett DE Jr, Nelkin BD, Baylin SB. Expression of an exogenous eukaryotic DNA methyltransferase gene induces transformation of NIH 3T3 cells. Proc Natl Acad Sci USA 1993; 90:8891-5.
6. Robertson KD, Uzvolgyi E, LIang G, Talmadge C, Sumegi J, Gonzales FA, et al. The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors. Nucleic Acids Res 1999; 27:2291-8.
7. Wang YA, Kamarova Y, Shen KC, Jiang Z, Hahn MJ, Wang Y, et al. DNA methyltransferase-3a interacts with p53 and represses p53-mediated gene expression. Cancer Biol Ther 2005; 4:1138-43.
8. Chi P, Allis CD, Wang GG. Covalent histone modifications: miswritten, misinterpreted and mis-erased in human cancers. Nat Rev Cancer 2010; 10:457-69.
9. Cedar H, Bergman Y. Linking DNA methylation and histone modification: patterns and paradigms. Nat Rev Genet 2009; 10:295-304.
10. Bernstein BE, Mikkelsen TS, Xie X, Kamal M, Huebert DJ, Cuff J, et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 2006; 125:315-26.
11. Mikkelsen TS, Ku M, Jaffe DB, Issac B, Lieberman E, Giannoukos G, et al. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 2007; 448:553-60.
12. Reik W. Stability and flexibility of epigenetic gene regulation in mammalian development. Nature 2007; 447:425-32.
13. Feinberg AP, Ohlsson R, Henikoff S. The epigenetic progenitor origin of human cancer. Nat Rev Genet 2006; 7:21-33.
14. Cui H. et al. Loss of IGF2 imprinting: a potential marker of colorectal cancer risk. Science 2003; 299:1753-5.
15. Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, Baylin SB. Methylation of the oestrogen receptor CpG island links aging and neoplasia in human colon. Nature Genet 1994; 7:536-40.
16. Baylin SB, Ohm JE. Epigenetic gene silencing in cancer-a mechanism for early oncogenic pathway addiction? Nat Rev Cancer 2006; 6:107-16.
17. Dahl C, Guldberg P. The genome and epigenome of malignant melanoma. APMIS 2007; 115:1161-76.
18. Houghton AN, Polsky D. Focus on melanoma. Cancer cell 2002; 2:275-8.
19. Oba-Shinjo SM, Correa M, Ricca TI, Molognoni F, Pinhal MA, Neves IA, et al. Melanocyte transformation associated with substrate adhesion impediment. Neoplasia 2006; 8:231-41.
20. Ricca TI, Liang G, Suenaga AP, Han SW, Jones PA, Jasiulionis MG. Tissue inhibitor of metalloproteinase 1 expression associated with gene demethylation confers anoikis resistance in early phases of melanocyte malignant transformation. Transl Oncol 2009; 2:329-40.
21. Silva AG, Graves HA, Guffei A, Ricca TI, Mortara RA, Jasiulionis MG, Mai S. Telomere-centromere-driven genomic instability contributes to karyotype evolution in a mouse model of melanoma. Neoplasia 2010; 12:11-9.
22. Campos AC, Molognoni F, Melo FH, Galdieri LC, Carneiro CR, D'Almeida V, et al. Oxidative stress modulates DNA methylation by endogenous nitric oxide during cell substrate adhesion blockade. Neoplasia 2007; 9:1111-21.
23. Robertson KD. DNA methylation, methyltransferases and cancer. Oncogene 2001; 20:3139-55.
24. Guz J, Foksinski M, Olinski R. Global DNA hipomethylation: the meaning in carcinogenesis. Postepy Biochem 2010; 56:16-21.
25. McCabe MT, Davis JN, Day ML. Regulation of DNA methyltransferase 1 by the pRb/E2F1 pathway. Cancer Res 2005; 65:3624-32.
26. Bogdanovic O, Veenstra GJ. DNA methylation and methyl-CpG binding proteins: developmental requirements and function. Chromosoma 2009; 118:549-65.
27. Tachibana M, Matsumura Y, Fukuda M, Kimura H, Shinkai Y. G9a/GLP complexes independently mediate H3K9 and DNA methylation to silence transcription. EMBO J 2008; 27:2681-90.
28. Lehnertz B, Ueda Y, Derijck AA, Braunschweig U, Perez-Burgos L, Kubicek S, et al. Suv39 h-mediated histone H3 lysine 9 methylation directs DNA methylation to major satellite repeats at pericentric heterochromatin. Curr Biol 2003; 13:1192-200.
29. Bapat SA, Jin V, Berry N, Balch C, Sharma N, Kurrey N, et al. Multivalent epigenetic marks confer microenvironment-responsive epigenetic plasticity to ovarian cancer cells. Epigenetics 2010; 5; [Epub ahead of print].
30. Pinskaya M, Morillon A. Histone H3 lysine 4 di-methylation: a novel mark for transcriptional fidelity? Epigenetic 2009; 4:302-6.
31. Jenuwein T, Allis CD. Translating the histone code. Science 2001; 293:1074-80.
32. Simon JA, Lange CA. Roles of the EZH2 histone methyltransferase in cancer epigenetics. Mutat Res 2008; 647:21-9.
33. Yi J, Luo J. SIRT1 and p53, effect on cancer, senescence and beyond. Biochim Biophys Acta 2010; 1804:1684-9.
34. Persson J, Ekwall K. Chd1 remodelers maintain open chromatin and regulate the epigenetics of differentiation. Exp Cell Res 2010; 316:1316-23.
35. Bjornsson HT, Fallin MD, Feinberg AP. An integrated epigenetic and genetic approach to common human disease. Trends Genet 2004; 20:350-8.
36. Bode AM, Dong Z. Cancer prevention research-then and now. Nat Rev Cancer 2009; 9:508-16.
37. Islami F, Boffetta P, Ren JS, Pedoeim L, Khatib D, Kamangar F. High-temperature beverages and foods and esophageal cancer risk: a systematic. Int J Cancer 2009; 125:491-524.
38. Tucker MA. Melanoma epidemiology. Hematol Oncol Clin North Am 2009; 23:383-95.
39. Cedar H, Bergman Y. Linking DNA methylation and histone modification: patterns and paradigms. Nat Rev Genet 2009; 10:295-304.
40. Gallagher WM, Bergin OE, Rafferty M, Kelly ZD, Nolan IM, Fox EJ, et al. Multiple markers for melanoma progression regulated by DNA methylation: insights from transcriptomic studies. Carcinogenesis 2005; 26:1856-67.
41. Muthusamy V, Duraisamy S, Bradbury CM, Hobbs C, Curley DP, Nelson B, et al. Epigenetic silencing of novel tumor suppressors in malignant melanoma. Cancer Res 2006; 66:11187-93.
42. Klisovic DD, Katz SE, Effron D, Klisovic MI, Wickham J, Parthun MR, et al. Depsipeptide (FR901228) inhibits proliferation and induces apoptosis in primary and metastatic human uveal melanoma cell lines. Invest Ophthalmol Vis Sci 2003; 44:2390-8.
43. van der Velden PA, Zuidervaart W, Hurks MH, Pavey S, Ksander BR, Krijgsman E, et al. Expression profiling reveals that methylation of TIMP3 is involved in uveal melanoma development. Int J Cancer 2003; 106:472-9.
44. Marini A, Mirmohammadsadegh A, Nambiar S, Gustrau A, Ruzicka T, Hengge UR. Epigenetic inactivation of tumor suppressor genes in serum of patients with cutaneous melanoma. J Invest Dermatol 2006 126:422-31.
45. Liu S, Ren S, Howell P, Fodstad O, Riker AI. Identification of novel epigenetically modified genes in human melanoma via promoter methylation gene profiling. Pigment Cell Melanoma Res 2008; 21:545-58.
46. Thiery JP. Epithelial-mesenchymal transitions in cancer onset and progression. Bull Acad Natl Med 2009; 193:1969-78.
47. Gaspar-Maia A, Alajem A, Polesso F, Sridharan R, Mason MJ, Heidersbach A, et al. Chd1 regulates open chromatin and pluripotency of embryonic stem cells. Nature 2009; 13:863-8.
48. Sims RJ, 3rd, Reinberg D. Stem cells: Escaping fates with open states. Nature 2009; 13:802-3.
49. Szutorisz H, Georgiou A, Tora L, Dillon N. The proteasome restricts permissive transcription at tissue-specific gene loci in embryonic stem cells. Cell 2006; 127:1375-88.
50. Calvanese V, Lara E, Suárez-Alvarez B, Abu Dawud R, Vázquez-Chantada M, Martínez-Chantar ML, et al. Sirtuin 1 regulation of developmental genes during differentiation of stem cells. Proc Natl Acad Sci USA 2010; 107:13736-41.
51. Bjelland S, Seeberg E. Mutagenicity, toxicity and repair of DNA base damage induced by oxidation. Mutat Res 2003; 531:37-80.
52. Escargueil AE, Soares DG, Salvador M, Larsen AK, Henriques JA. What histone code for DNA repair? Mutat Res 2008; 658:259-70.
53. Smerdon MJ. DNA repair and the role of chromatin structure. Curr Opin Cell Biol 1991; 3:422-8.
54. Amouroux R, Campalans A, Epe B, Radicella JP. Oxidative stress triggers the preferential assembly of base excision repair complexes on open chromatin regions. Nucleic Acids Res 2010; 38:2878-90.
55. Costes SV, Chiolo I, Pluth JM, Barcellos-Hoff MH, Jakob B. Spatiotemporal characterization of ionizing radiation induced DNA damage foci and their relation to chromatin organization. Mutat Res 2010; 704:78-87.
56. Suter B, Livingstone-Zatchej M, Thoma F. Chromatin structure modulates DNA repair by photolyase in vivo. EMBO J 1997; 16:2150-60.
57. O'Hagan HM, Mohammad HP, Baylin SB. Double strand breaks can initiate gene silencing and SIRT1-dependent onset of DNA methylation in an exogenous promoter CpG island. PLoS Genet 2008; 4:1000155.
58. Bennett DC, Cooper PJ, Hart IR. A line of non-tumorigenic mouse melanocytes, syngeneic with the B16 melanoma and requiring a tumour promoter for growth. Int J Cancer 1987; 39:414-8.
59. Gonzalgo ML, Jones PA. Quantitative methylation analysis using methylation-sensitive single-nucleotide primer extension (Ms-SNuPE). Methods 2002; 27:128-33.